Contributor Disclosures for Paget Disease

Role Name Disclosure Details Author  Laura D Carbone, MD, Associate Professor of Medicine, Division of Connective Health Diseases, Director , Memphis Metabolic Bone Center, Department of Medicine, University of Tennessee Health Science Center College of Medicine merck merck novartis P&G P&G aventis aventis Details Coauthor  Karen Barrow, MS, Data Analyst, Departments of Preventive Medicine and Medicine, University of Tennessee Health Science Center Nothing to disclose Details Coauthor  Kristine M Lohr, MD, Associate Chief, Program Director, Professor, Department of Internal Medicine, Division of Rheumatology, University of Tennessee School of Medicine Nothing to disclose Details Coauthor  Marlon J Navarro, MD, Fellow, Department of Rheumatology, University of Tennessee at Memphis Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Elliot Goldberg, MD, Dean of the Western Pennsylvania Clinical Campus, Professor, Department of Medicine, Temple University School of Medicine Nothing to disclose Details CME Editor  Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine Nothing to disclose Details Chief Editor  Herbert S Diamond, MD, Professor of Medicine, Temple University School of Medicine; Chairman, Department of Internal Medicine, Western Pennsylvania Hospital medifocus health dialogs Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott, West Penn Allegheny Health System Pfizer Proctor&Gamble, Amgen, Pfizer Details CONTRIBUTOR DISCLOSURE FORM Contributor Name: Laura D Carbone  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** merck Honoraria Consulting   merck Honoraria Speaking and teaching   novartis Honoraria Consulting   P&G Honoraria Consulting   P&G Honoraria Speaking and teaching   aventis Honoraria Consulting   aventis Honoraria Speaking and teaching   Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Karen Barrow, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Kristine M Lohr, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Marlon J Navarro, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Elliot Goldberg  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Alex J Mechaber, CME Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Herbert S Diamond  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** medifocus Honoraria Review panel membership   health dialogs Honoraria Consulting   Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott, Ownership interest Other   West Penn Allegheny Health System Salary Employment   Pfizer Honoraria Consulting   Proctor&Gamble, Amgen, Pfizer Grant/research funds Independent contractor   Off label or investigational use of medication